JP2023503852A5 - - Google Patents

Info

Publication number
JP2023503852A5
JP2023503852A5 JP2022527989A JP2022527989A JP2023503852A5 JP 2023503852 A5 JP2023503852 A5 JP 2023503852A5 JP 2022527989 A JP2022527989 A JP 2022527989A JP 2022527989 A JP2022527989 A JP 2022527989A JP 2023503852 A5 JP2023503852 A5 JP 2023503852A5
Authority
JP
Japan
Prior art keywords
methyl
pyridine
oxy
piperidine
dichlorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022527989A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023503852A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/060108 external-priority patent/WO2021097009A1/en
Publication of JP2023503852A publication Critical patent/JP2023503852A/ja
Publication of JP2023503852A5 publication Critical patent/JP2023503852A5/ja
Pending legal-status Critical Current

Links

JP2022527989A 2019-11-12 2020-11-12 感染症を処置するための低分子フーリン阻害剤 Pending JP2023503852A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962934407P 2019-11-12 2019-11-12
US62/934,407 2019-11-12
PCT/US2020/060108 WO2021097009A1 (en) 2019-11-12 2020-11-12 Small molecule furin inhibitors for treating infectious diseases

Publications (2)

Publication Number Publication Date
JP2023503852A JP2023503852A (ja) 2023-02-01
JP2023503852A5 true JP2023503852A5 (enExample) 2023-11-20

Family

ID=73793799

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022527989A Pending JP2023503852A (ja) 2019-11-12 2020-11-12 感染症を処置するための低分子フーリン阻害剤

Country Status (8)

Country Link
US (1) US20230011571A1 (enExample)
EP (1) EP4058021A1 (enExample)
JP (1) JP2023503852A (enExample)
KR (1) KR20220104744A (enExample)
CN (1) CN114929220A (enExample)
AU (1) AU2020382819A1 (enExample)
CA (1) CA3157892A1 (enExample)
WO (1) WO2021097009A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112384509B (zh) 2018-05-11 2024-04-30 葛兰素史密斯克莱知识产权发展有限公司 弗林蛋白酶抑制剂
DE102023126563A1 (de) * 2023-09-28 2025-04-03 Philipps-Universität Marburg, Körperschaft des öffentlichen Rechts Hemmstoffe der Proproteinkonvertase Furin, Verfahren zu deren Herstellung und Verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037346A1 (en) * 2001-10-31 2003-05-08 Cell Therapeutics, Inc. 6-phenyl-n-phenyl-(1,3,5) -triazine-2,4-diamine derivatives and related compounds with lysophphosphatidic acid acyltransferase beta (lpaat-beta) inhibitory activity for use in the treatment of cancer
CA2687024A1 (en) 2007-05-09 2009-02-19 Burnham Institute For Medical Research Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
WO2013138666A1 (en) 2012-03-16 2013-09-19 Sanford-Burnham Medical Research Institute Inhibitors of furin and other pro-protein convertases
WO2014152716A1 (en) * 2013-03-15 2014-09-25 President And Fellows Of Harvard College Substituted heterocyclic compounds for treating or preventing viral infections
CN107441094B (zh) * 2017-08-08 2020-05-22 南方医科大学 尼罗替尼作为治疗登革病毒感染的药物及其制药用途
CN112384509B (zh) * 2018-05-11 2024-04-30 葛兰素史密斯克莱知识产权发展有限公司 弗林蛋白酶抑制剂

Similar Documents

Publication Publication Date Title
JP2021523941A5 (enExample)
IL278642B1 (en) Purine inhibitors
NL2000323C2 (nl) Pyrimidine-derivaten.
US10004755B2 (en) Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity
ES2588680T3 (es) Compuestos de tiazolopirimidina
JP2019530739A5 (enExample)
KR101702609B1 (ko) 인플루엔자 바이러스 복제의 억제제
ES2401192T3 (es) Deazapurinas útiles como inhibidores de janus cinasas
ES2654051T3 (es) Pirrolo[2,3-d]pirimidinilo, pirrolo[2,3-b]pirazinilo y pirrolo[2,3-d]piridinil acrilamidas
ES2637295T3 (es) Compuestos de 6,7-dihidropirazolo[1,5-a]pirazin-4(5h)-ona y su uso como moduladores alostéricos negativos de receptores mGluR2
JP6229042B2 (ja) ビヘテロアリール化合物及びその使用
RU2399620C2 (ru) Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3
JP2022508705A (ja) ユビキチンプロテオソーム経路を介してbtkを分解するための二官能性化合物
JP2022501338A5 (enExample)
ES2708215T3 (es) Compuestos de 6,7-dihidropirazolo[1,5-a]pirazin-4(5H)-ona y su uso como moduladores alostéricos negativos de receptores MGLU2
ES2655971T9 (es) Compuestos de aminopirimidinilo como inhibidores de JAK
CN101883774A (zh) 噻吩并嘧啶和吡唑并嘧啶化合物及其用作mtor激酶和pi3激酶抑制剂的用途
US20140315886A1 (en) Quinazolines as therapeutic compounds and related methods of use
JP2021502400A (ja) 置換ピロロピリミジンjak阻害剤ならびにこれを作製および使用する方法
JP2003531210A5 (enExample)
AU2015308522A1 (en) Products for the treatment and prevention of neurological disorders coursing with a cognition deficit or impairment, and of neurodegenerative diseases
CN110291090A (zh) 作为新型jak激酶抑制剂的双环胺
CN114746414A (zh) 氮杂-喹啉化合物及其用途
HK1246781A1 (zh) 呼吸道合胞病毒抑制剂
JP2023521032A5 (enExample)